Lexaria Announces Positive Final Results From Human Pilot Study #5

Detailed price information for Lexaria Bioscience Corp (LEXX-Q) from The Globe and Mail including charting and trades.

Lexaria Bioscience Corp.: Lexaria Announces Positive Final Results From Human Pilot Study #5

Company Further Examining the Pursuit of the World's First Oral Liraglutide Product KELOWNA, BC / ACCESS Newswire / February 5, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX), (the "Company" or "Lexari ...